ACTION Registry (Acute Coronary Treatment and Intervention Outcomes Network) Initial Report 1st Quarter 2007 Results Report prepared by: www. ncdr.com.

Slides:



Advertisements
Similar presentations
ACC/AHA Classification of Care Metrics
Advertisements

1 Outcomes for Patients with ST-Elevation Myocardial Infarction in Hospitals With and Without Onsite Coronary Artery Bypass Graft Surgery: The New York.
Pexelizumab for the Reduction of Infarction and Mortality in Coronary Artery Bypass Graft ll (PRIMO-CABG II) Trial Presented at The American College of.
Listening to the Data: Why There’s Room for Improvement in MI Care Heartscape® Consultants Meeting Charles V. Pollack, Jr, MA, MD, FACEP, FAAEM, FAHA Chairman,
Decline in the Use of Drug-Eluting Stents for Patients With NSTEMI Undergoing PCI: Results From the CRUSADE and ACTION Registries Matthew T. Roe, Christopher.
What Have We Learned from the CRUSADE Registry
Eric D. Peterson, MD, MPH Professor of Medicine, Vice Chair for Quality Duke University Medical Center Associate Director & Director of CV Research Duke.
Sumeet Subherwal, Richard G. Bach, Anita Y. Chen, Brian F. Gage, Sunil V. Rao, Tracy Y. Wang, W. Brian Gibler, E. Magnus Ohman, Matthew T. Roe, Eric D.
Connie N. Hess, MD, Bimal R. Shah, MD, MBA, S. Andrew Peng, MS, Laine Thomas, PhD, Matthew T. Roe, MD, MHS, Eric D. Peterson, MD, MPH Relationship of Early.
NCDR Update Board of Governors Meeting September 16, 2007 John Brush, MD, FACC Chair, Quality Strategic Directions Committee ACC Governor, Virginia Chapter.
Comparison of the New Mayo Clinic Risk Scores and Clinical SYNTAX Score in Predicting Adverse Cardiovascular Outcomes following Percutaneous Coronary Intervention.
Anterior Depressions Angiographic and Clinical Outcomes Among Patients with Acute Coronary Syndromes Presenting with Anterior ST-Segment Depressions C.
Development of Clinical Pathways to Streamline Care for Patients Presenting with Suspected Cardiac Chest Pain Background The National Heart Foundation.
Improved Care for Acute Myocardial Infarction Linking Referral and Receiving Centres – How can We Communicate Better? Dr. James McMeekin AMI Faculty Cardiologist,
Clinical Trial Results. org Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention.
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
QI ACTION Registry-Get With The Guidelines The Mission Lifeline Data Solution Kathleen O’Neill, MHA Senior Director, Quality Initiatives IL & SD American.
Amr Hassan Mostafa, MD, FSCAI A. Professor of Cardiology Cairo University Cairo, Egypt Egypt Combat MI, March 24-25, Cairo Sheraton.
CRUSADE: A National Quality Improvement Initiative CRUSADE: A National Quality Improvement Initiative Can Rapid Risk Stratification of Unstable Angina.
1 1 The Use of Percutaneous Coronary Intervention in Patients with Class I Indications for Coronary Artery Bypass Graft Surgery: Data from the National.
ACUTE CORONARY SYNDROME (ACS). ACS Pathophysiology is that of a ruptured or eroded atheromatous plaque. Pathophysiology is that of a ruptured or eroded.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
Patterns of red blood cell transfusion use and outcomes in patients undergoing percutaneous coronary intervention in contemporary clinical practice: Insights.
Partner meeting Aprile, Alberto Cremonesi.
STRIVE TM What Is the Evidence That Critical Pathways Work? UCLA Cardiac Hospitalization Atherosclerosis Management Program (CHAMP) ACC Guidelines Applied.
ACS Clinical Pathway. Who? Pts with Acute Ischemic Heart Disease now described as having ACS.
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
The IC 3 (Improving Continuous Cardiac Care) - PINNACLE Program: A Report of the first 14,000+ Patients Paul S. Chan, MD MScWilliam J. Oetgen, MD Donna.
Incremental Decrease in Clinical Endpoints Through Aggressive Lipid Lowering (IDEAL) Trial IDEAL Trial Presented at The American Heart Association Scientific.
Background Current guideline recommend an early invasive strategy for NSTEMI patients (Class IIA). However, 67% US hospitals have no catheterization capability.
ACTION Registry. Objectives of the NCDR Registries Provide data standardization Provide data that is –Relevant, Credible, Timely, Actionable Present real.
0009COR1 A CRUSADE to Improve Quality of Care for ACS Patients Eric D. Peterson, MD, MPH Associate Professor of Medicine Director of CV Outcomes and Quality.
Naotsugu Oyama, MD, PhD, MBA A Trial of PLATelet inhibition and Patient Outcomes.
6/04 CRUSADE: A National Quality Improvement Initiative C an R apid Risk Stratification of U nstable Angina Patients S uppress AD verse Outcomes with E.
Bleeding in Patients Undergoing Percutaneous Coronary Interventions: A Risk Model From 302,152 Patients in the NCDR. Sameer K. Mehta MD, Andrew D. Frutkin.
CP CathPCI Registry 10 Years and We Keep Going.
Clinical Trial Results. org Characteristics, Management, and Outcomes of 5,557 Patients Age ≥90 Years With Acute Coronary Syndromes: Results From the CRUSADE.
Trends in the Quality of Care of Patients with Acute Myocardial Infarction: The National Registry of Myocardial Infarction from 1990 to 2006 Bimal R. Shah,
Acute Coronary Syndromes Risk-Stratification Pathophysiology Diagnosis Initial Therapy Risk-Stratification Risk-Stratification Invasive vs Conservative.
Impact of Prior Myocardial Infarction Among Patients with Acute Myocardial Infarction Treated in Contemporary Practice: A Report from the ACTION Registry.
Balloon-pump assisted Coronary Intervention Study BCIS-1 Simon Redwood Divaka Perera, Rod Stables, Martyn Thomas.
Risk Stratification in Unstable Angina Prospective Validation of the Braunwald Classification JAMA, January 11, 1995-Vol.273,No. 2.
Antiplatelet Therapy Use after Discharge among Acute Myocardial Infarction Patients with In-hospital Bleeding Tracy Y. Wang, MD, MHS, Lan Xiao, PhD, Karen.
Management of Patients with NSTE ACS Latest Insights from CRUSADE A National Quality Improvement Initiative Eric D. Peterson, MD, MPH Duke Clinical Research.
Cardioprotective Effects of Postconditioning in Patients Treated with Primary PCI Evaluated with Magnetic Resonance Jacob T Lønborg Niels Vejlstrup, Erik.
Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Nuisance Bleeding With Prolonged Dual Antiplatelet.
Transitions in Care-Heart Failure
A Clinical profile of patients enrolled in the Pakistan ACS registry
Risk Stratification of Chest Pain: Best Practices
Copyright © 2008 American Medical Association. All rights reserved.
Copyright © 2005 American Medical Association. All rights reserved.
Copyright © 2009 American Medical Association. All rights reserved.
On behalf of J. Belardi, M. Leon, L. Mauri,
Coronary Catheterization and Percutaneous Coronary Intervention in China 10-Year Results From the China PEACE-Retrospective CathPCI Study Xin Zheng,
Section A: Introduction
European Heart Association Journal 2007 April
Figure 1 PCI strategies in patients with STEMI and multivessel disease
2006 CRUSADE 2nd Quarter Results
Antiplatelet Therapy Use after Discharge among Acute Myocardial Infarction Patients with In-hospital Bleeding Tracy Y. Wang, MD, MHS, Lan Xiao, PhD, Karen.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Global Registry of Acute Coronary Events: GRACE
Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris  Toshihiro Fukui,
What Have We Learned from the CRUSADE Registry
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
ARISE Trial Aggressive Reduction of Inflammation Stops Events
Long Term Clinical Results from the Endeavor Program: 5-Year Follow up
Urban–Rural Comparisons in Hospital Admission, Treatments, and Outcomes for ST-Segment–Elevation Myocardial Infarction in China From 2001 to 2011 A Retrospective.
ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective.
Cardiovascular Epidemiology and Epidemiological Modelling
Many post-MI patients are not receiving optimal therapy
Presentation transcript:

ACTION Registry (Acute Coronary Treatment and Intervention Outcomes Network) Initial Report 1st Quarter 2007 Results Report prepared by: www. ncdr.com

Background Recent studies have demonstrated that guidelines adherence is sub-optimal for a large proportion of ACS patients. The ACTION Registry has been created to enable hospitals to measure and improve their performance in treating patients with ACS against national benchmarks. Contained in this report are performance information from the harvest from CRUSADE and the ACTION Registry.

The ACTION Registry Represents the merger of two of the nations premier ACS registries: –NRMI (National Registry of Myocardial Infarction) –CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC and AHA Guidelines) Unified under the leadership and support of NCDR : –Guidelines, performance indictors, and data standard alignment –Clinical/technical/contract support –Training and orientation www. ncdr.com

Goals of the ACTION Registry The nations ACS surveillance system –Assess characteristics, treatments, and outcomes of patients hospitalized with STEMI and NSTEMI Optimize the care and outcomes of ACS patients –Implement ALL evidence-based guideline recommendations in clinical practice –Assure that the right things are done right (safe and timely). Facilitate efforts to improve ACS care quality and safety via novel QI improvement methods

ACTION QI Tool Development Quarterly feedback reports Individualized GAP analysis On-line, real-time summaries QI tool kits D2B tool kits Monthly Webcasts Regional group meetings Take ACTION Campaign

Data Submission Summary Admission # of # of # of Timeframe Sites NSTEMI Records STEMI Records ACTION Jan. 1, 2007 – 227 6,917 4,259 Mar. 31, 2007 CRUSADE April 1, 2006 – ,084 4,391 Dec. 31, 2006

ACTION Registry 2007 Patient Enrollment Number of Patients enrolled

Complexity of NSTEMI Pts Baseline Characteristics NSTEMI Variable (n = 26,902) Mean age ± SD (yrs) 69 ± 14 Female Diabetes mellitus Prior MI Prior CHF Prior PCI Prior CABG ACTION/CRUSADE DATA: April 1, 2006 – May 31, 2007 (n=26,902) 40% 33% 29% 16% 23% 19%

Hospital Presentation Variable NSTEMI (n = 26,902) Qualifying criteria ST-segment depression Transient ST-segment elevation Presenting characteristics Tachycardia Hypotension Signs of CHF ACTION/CRUSADE DATA: April 1, 2006 – May 31, 2007 (n=26,902) 25% 4% 22% 3% 22%

In-Hospital Outcomes Variable NSTEMI (n = 26,902) Death Re-infarction CHF Cardiogenic Shock Stroke RBC Transfusion* *Excluding CABG patients ACTION/CRUSADE DATA: April 1, 2006 – May 31, 2007 (n=26,902) *Excluding CABG patients ACTION/CRUSADE DATA: April 1, 2006 – May 31, 2007 (n=26,902) 3.8% 1.5% 6.8% 2.4% 0.7% 8.9%

NSTEMI Acute Medications ACTION/CRUSADE DATA: April 1, 2006 – May 31, 2007

NSTEMI Invasive Cardiac Procedures ACTION/CRUSADE DATA: April 1, 2006 – May 31, 2007

*LVEF < 40%, CHF, DM, HTN # Known hyperlipidemia, TC, LDL ACTION/CRUSADE DATA: April 1, 2006 – May 31, 2007 (n= 26,902) NSTEMI Discharge Medications % Use

NSTEMI Discharge Interventions ACTION/CRUSADE DATA: April 1, 2006 – May 31, 2007